Director at First Tracks Biotherapeutics (TRAX) gets equity awards
Rhea-AI Filing Summary
First Tracks Biotherapeutics, Inc. director Magda Marquet received equity-based compensation awards. She was granted stock options for 7,000 shares of common stock at an exercise price of 17.81 per share, expiring on May 11, 2036, and 2,500 restricted stock units. The options vest in 12 equal monthly installments starting June 12, 2026, while all RSUs vest on the date of the company’s 2027 annual shareholders meeting, in each case subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Marquet Magda
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 2,500 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 7,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 2,500 shares (Direct);
Stock Option (right to buy) — 7,000 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F2. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- F3. The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Option grant size: 7,000 shares
Option exercise price: 17.81 per share
Option expiration: May 11, 2036
+3 more
6 metrics
Option grant size
7,000 shares
Stock options to buy common stock granted on May 12, 2026
Option exercise price
17.81 per share
Exercise price for 7,000 stock options
Option expiration
May 11, 2036
Expiration date of the 7,000 stock options
RSU grant size
2,500 units
Restricted stock units linked to common stock
RSU vesting
100% on 2027 meeting date
Vests on First Tracks Biotherapeutics’ 2027 annual shareholders meeting
Option vesting schedule
1/12 monthly from June 12, 2026
Monthly vesting until fully vested, subject to service
Key Terms
Restricted Stock Unit, contingent right, vests, stock option, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration"
vests financial
"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders"
stock option financial
"The stock option vests as to 1/12 of the total shares monthly"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"Stock Option (right to buy) with a conversion or exercise price of 17.8100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Magda Marquet report for First Tracks Biotherapeutics (TRAX)?
Magda Marquet reported receiving equity awards, not market trades. She was granted stock options for 7,000 shares and 2,500 restricted stock units, both tied to First Tracks Biotherapeutics common stock, as part of her compensation for serving as a director.
How many stock options were granted to Magda Marquet at First Tracks Biotherapeutics (TRAX)?
She was granted options covering 7,000 shares of common stock. These options carry an exercise price of 17.81 per share and expire on May 11, 2036, giving her the right to purchase shares if she chooses to exercise before expiration.
What are the terms of the restricted stock units granted to Magda Marquet at TRAX?
Magda Marquet received 2,500 restricted stock units. Each RSU represents a contingent right to receive one common share for no cash consideration, vesting 100% on the date of First Tracks Biotherapeutics’ 2027 annual shareholders meeting, subject to her continued service.
How do Magda Marquet’s stock options at First Tracks Biotherapeutics vest?
The 7,000 stock options vest in 12 equal monthly installments. Vesting begins June 12, 2026, with one-twelfth of the options vesting each month, contingent on Magda Marquet continuing to provide service to First Tracks Biotherapeutics on each vesting date.
Does Magda Marquet’s Form 4/A for TRAX show any stock sales or purchases on the market?
The Form 4/A shows only grant or award acquisitions, not open-market trades. Both reported transactions are coded as awards of derivatives, reflecting compensation in the form of options and restricted stock units rather than buying or selling existing shares.